JUAN MARÍA DE LA
OBRA SIERRA
Ikertzailea 1988-2015 tartean
Hospital Universitario Central de Asturias
Oviedo, EspañaHospital Universitario Central de Asturias -ko ikertzaileekin lankidetzan egindako argitalpenak (12)
2021
-
Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
Nature Communications, Vol. 12, Núm. 1
-
Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage
Nature Communications, Vol. 12, Núm. 1
2020
-
Regulatory sites for splicing in human basal ganglia are enriched for disease-relevant information
Nature Communications, Vol. 11, Núm. 1
2019
-
Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset
npj Parkinson's Disease, Vol. 5, Núm. 1
-
Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability
npj Parkinson's Disease, Vol. 5, Núm. 1
-
SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease
Movement Disorders, Vol. 34, Núm. 9, pp. 1333-1344
-
The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight
Movement Disorders, Vol. 34, Núm. 12, pp. 1851-1863
2016
2013
2012
-
Common variation in the LRRK2 gene is a risk factor for Parkinson's disease
Movement Disorders, Vol. 27, Núm. 14, pp. 1823-1826
-
levodopa en el tratamiento de la enfermedad de parkinson: Mitos y realidades
Revista de Neurologia, Vol. 55, Núm. 11, pp. 669-688
2011
-
Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease
Movement Disorders, Vol. 26, Núm. 5, pp. 819-823